Jack Ayre
Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs for Extending the Lung Tissue Retention of Inhaled Drugs
Ayre, Jack; Redmond, Joanna M; Vitulli, Giovanni; Tomlinson, Laura; Weaver, Richard; Comeo, Eleonora; Bosquillon, Cynthia; Stocks, Michael J.
Authors
Joanna M Redmond
Giovanni Vitulli
Laura Tomlinson
Richard Weaver
Eleonora Comeo
CYNTHIA BOSQUILLON cynthia.bosquillon@nottingham.ac.uk
Assistant Professor
MICHAEL STOCKS MICHAEL.STOCKS@NOTTINGHAM.AC.UK
Professor of Medicinal Chemistry and Drug Discovery
Abstract
A major limitation of pulmonary delivery is that drugs can exhibit suboptimal pharmacokinetic profiles resulting from rapid elimination from the pulmonary tissue. This can lead to systemic side effects and a short duration of action. A series of dibasic dipeptides attached to the poorly lung-retentive muscarinic M3 receptor antagonist piperidin-4-yl 2-hydroxy-2,2-diphenylacetate (1) through a pH-sensitive-linking group have been evaluated. Extensive optimization resulted in 1-(((R)-2-((S)-2,6-diaminohexanamido)-3,3-dimethylbutanoyl)oxy)ethyl 4-(2-hydroxy-2,2-diphenylacetoxy)piperidine-1-carboxylate (23), which combined very good in vitro stability and very high rat lung binding. Compound 23 progressed to pharmacokinetic studies in rats, where, at 24 h post dosing in the rat lung, the total lung concentration of 23 was 31.2 μM. In addition, high levels of liberated drug 1 were still detected locally, demonstrating the benefit of this novel prodrug approach for increasing the apparent pharmacokinetic half-life of drugs in the lungs following pulmonary dosing.
Citation
Ayre, J., Redmond, J. M., Vitulli, G., Tomlinson, L., Weaver, R., Comeo, E., …Stocks, M. J. (2022). Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs for Extending the Lung Tissue Retention of Inhaled Drugs. Journal of Medicinal Chemistry, 65(14), 9802-9818. https://doi.org/10.1021/acs.jmedchem.2c00416
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 24, 2022 |
Online Publication Date | Jul 7, 2022 |
Publication Date | Jul 28, 2022 |
Deposit Date | Jul 1, 2022 |
Publicly Available Date | Jul 8, 2023 |
Journal | Journal of medicinal chemistry |
Print ISSN | 0022-2623 |
Electronic ISSN | 1520-4804 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 65 |
Issue | 14 |
Pages | 9802-9818 |
DOI | https://doi.org/10.1021/acs.jmedchem.2c00416 |
Keywords | Drug Discovery; Molecular Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/8769944 |
Publisher URL | https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00416 |
Files
Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs
(3.2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search